(APVO) |
| 0 (0%) 05-29 15:05 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 5.62 |
| Resistance 1: | 5.10 |
| Pivot price: | 4.82 |
| Support 1: | 4.25 |
| Support 2: | 3.54 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -87.270 |
| Book Value | 9.650 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -118.0 |
| Return on Equity (ttm) | -517.9 |
Company news
Thu, 28 May 2026
Aptevo Therapeutics (APVO) SVP, CSO files Form 3 reporting zero shares - Stock Titan
Thu, 28 May 2026
Oncology R&D leader to guide Aptevo's multispecific cancer pipeline - Stock Titan
Wed, 27 May 2026
Aptevo Therapeutics (APVO) Forms Strategic Collaboration with Ni - GuruFocus
Wed, 27 May 2026
Niowave takes 7.9% Aptevo stake in cancer radiopharma tie-up - Stock Titan
Fri, 22 May 2026
APVO News | APTEVO THERAPEUTICS INC (NASDAQ:APVO) - ChartMill
Wed, 20 May 2026
All you need to know about Aptevo Therapeutics (APVO) rating upgrade to buy - MSN
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
